カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界のラコサミド錠市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Lacosamide Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7900）・商品コード：GIR23SM7900
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のラコサミド錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のラコサミド錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ラコサミド錠の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ラコサミド錠市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・50mg/錠、100mg/錠、150mg/錠、200mg/錠

用途別セグメント
・大人、子供

主要な市場プレーヤー
・UCB、Aesica Pharmaceuticals GmbH、Teva、MSN Laboratories、Alembic Pharma、Glenmark、Accord Healthcare、Mylan、Sun PharmaApotex、Jiangxi Qingfeng Pharmaceutical、Beijing Sihuan Pharmaceutical、Buchang Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ラコサミド錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なラコサミド錠メーカーの企業概要、2019年～2022年までのラコサミド錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なラコサミド錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ラコサミド錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのラコサミド錠のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのラコサミド錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびラコサミド錠の産業チェーンを掲載しています。
・第14、15章では、ラコサミド錠の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ラコサミド錠の概要
– タイプ別分析（2018年vs2022年vs2029年）：50mg/錠、100mg/錠、150mg/錠、200mg/錠
– 用途別分析（2018年vs2022年vs2029年）：大人、子供
– 世界のラコサミド錠市場規模・予測
– 世界のラコサミド錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– UCB、Aesica Pharmaceuticals GmbH、Teva、MSN Laboratories、Alembic Pharma、Glenmark、Accord Healthcare、Mylan、Sun PharmaApotex、Jiangxi Qingfeng Pharmaceutical、Beijing Sihuan Pharmaceutical、Buchang Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：50mg/錠、100mg/錠、150mg/錠、200mg/錠
・用途別分析2018年-2029年：大人、子供
・ラコサミド錠の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ラコサミド錠のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ラコサミド錠のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ラコサミド錠の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ラコサミド錠の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Lacosamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg/tablet
1.3.3 100 mg/tablet
1.3.4 150 mg/tablet
1.3.5 200 mg/tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Lacosamide Tablets Market Size & Forecast
1.5.1 Global Lacosamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lacosamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Lacosamide Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Tablets Product and Services
2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 UCB Recent Developments/Updates
2.2 Aesica Pharmaceuticals GmbH
2.2.1 Aesica Pharmaceuticals GmbH Details
2.2.2 Aesica Pharmaceuticals GmbH Major Business
2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Lacosamide Tablets Product and Services
2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alembic Pharma Recent Developments/Updates
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Tablets Product and Services
2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Recent Developments/Updates
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Accord Healthcare Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Lacosamide Tablets Product and Services
2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 Sun PharmaApotex
2.9.1 Sun PharmaApotex Details
2.9.2 Sun PharmaApotex Major Business
2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun PharmaApotex Recent Developments/Updates
2.10 Jiangxi Qingfeng Pharmaceutical
2.10.1 Jiangxi Qingfeng Pharmaceutical Details
2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
2.11 Beijing Sihuan Pharmaceutical
2.11.1 Beijing Sihuan Pharmaceutical Details
2.11.2 Beijing Sihuan Pharmaceutical Major Business
2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
2.12 Buchang Pharmaceutical
2.12.1 Buchang Pharmaceutical Details
2.12.2 Buchang Pharmaceutical Major Business
2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Buchang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Lacosamide Tablets by Manufacturer
3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lacosamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Lacosamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Lacosamide Tablets Manufacturer Market Share in 2022
3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Lacosamide Tablets Market: Region Footprint
3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Lacosamide Tablets Market Size by Region
4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Lacosamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Lacosamide Tablets Average Price by Region (2018-2029)
4.2 North America Lacosamide Tablets Consumption Value (2018-2029)
4.3 Europe Lacosamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029)
4.5 South America Lacosamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Lacosamide Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Lacosamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Lacosamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Lacosamide Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Lacosamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Lacosamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Lacosamide Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Lacosamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Lacosamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Lacosamide Tablets Market Size by Country
7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Lacosamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Lacosamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Lacosamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Lacosamide Tablets Market Size by Country
8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Lacosamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Lacosamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Lacosamide Tablets Market Size by Country
10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Lacosamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Lacosamide Tablets Market Drivers
12.2 Lacosamide Tablets Market Restraints
12.3 Lacosamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lacosamide Tablets
13.3 Lacosamide Tablets Production Process
13.4 Lacosamide Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lacosamide Tablets Typical Distributors
14.3 Lacosamide Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. UCB Basic Information, Manufacturing Base and Competitors
Table 4. UCB Major Business
Table 5. UCB Lacosamide Tablets Product and Services
Table 6. UCB Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. UCB Recent Developments/Updates
Table 8. Aesica Pharmaceuticals GmbH Basic Information, Manufacturing Base and Competitors
Table 9. Aesica Pharmaceuticals GmbH Major Business
Table 10. Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
Table 11. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Aesica Pharmaceuticals GmbH Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Lacosamide Tablets Product and Services
Table 16. Teva Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. MSN Laboratories Major Business
Table 20. MSN Laboratories Lacosamide Tablets Product and Services
Table 21. MSN Laboratories Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MSN Laboratories Recent Developments/Updates
Table 23. Alembic Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharma Major Business
Table 25. Alembic Pharma Lacosamide Tablets Product and Services
Table 26. Alembic Pharma Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Alembic Pharma Recent Developments/Updates
Table 28. Glenmark Basic Information, Manufacturing Base and Competitors
Table 29. Glenmark Major Business
Table 30. Glenmark Lacosamide Tablets Product and Services
Table 31. Glenmark Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Glenmark Recent Developments/Updates
Table 33. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Accord Healthcare Major Business
Table 35. Accord Healthcare Lacosamide Tablets Product and Services
Table 36. Accord Healthcare Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Accord Healthcare Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Lacosamide Tablets Product and Services
Table 41. Mylan Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mylan Recent Developments/Updates
Table 43. Sun PharmaApotex Basic Information, Manufacturing Base and Competitors
Table 44. Sun PharmaApotex Major Business
Table 45. Sun PharmaApotex Lacosamide Tablets Product and Services
Table 46. Sun PharmaApotex Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun PharmaApotex Recent Developments/Updates
Table 48. Jiangxi Qingfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Jiangxi Qingfeng Pharmaceutical Major Business
Table 50. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
Table 51. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 53. Beijing Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Sihuan Pharmaceutical Major Business
Table 55. Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
Table 56. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 58. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Buchang Pharmaceutical Major Business
Table 60. Buchang Pharmaceutical Lacosamide Tablets Product and Services
Table 61. Buchang Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Buchang Pharmaceutical Recent Developments/Updates
Table 63. Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Lacosamide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Lacosamide Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Lacosamide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Lacosamide Tablets Production Site of Key Manufacturer
Table 68. Lacosamide Tablets Market: Company Product Type Footprint
Table 69. Lacosamide Tablets Market: Company Product Application Footprint
Table 70. Lacosamide Tablets New Market Entrants and Barriers to Market Entry
Table 71. Lacosamide Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Lacosamide Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Lacosamide Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Lacosamide Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Lacosamide Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Lacosamide Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Lacosamide Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Lacosamide Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Lacosamide Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Lacosamide Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Lacosamide Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Lacosamide Tablets Raw Material
Table 131. Key Manufacturers of Lacosamide Tablets Raw Materials
Table 132. Lacosamide Tablets Typical Distributors
Table 133. Lacosamide Tablets Typical Customers
List of Figures
Figure 1. Lacosamide Tablets Picture
Figure 2. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lacosamide Tablets Consumption Value Market Share by Type in 2022
Figure 4. 50 mg/tablet Examples
Figure 5. 100 mg/tablet Examples
Figure 6. 150 mg/tablet Examples
Figure 7. 200 mg/tablet Examples
Figure 8. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Lacosamide Tablets Consumption Value Market Share by Application in 2022
Figure 10. Adults Examples
Figure 11. Children Examples
Figure 12. Global Lacosamide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Lacosamide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Lacosamide Tablets Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Lacosamide Tablets Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Lacosamide Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Lacosamide Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Lacosamide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Lacosamide Tablets Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Lacosamide Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Lacosamide Tablets Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Lacosamide Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 54. China Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Lacosamide Tablets Market Drivers
Figure 75. Lacosamide Tablets Market Restraints
Figure 76. Lacosamide Tablets Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Lacosamide Tablets in 2022
Figure 79. Manufacturing Process Analysis of Lacosamide Tablets
Figure 80. Lacosamide Tablets Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


★調査レポート[世界のラコサミド錠市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7900)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のラコサミド錠市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のベンダゾール錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のボスチニブ一水和物錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のペントキシフィリン腸溶錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のニコランジル錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のコハク酸ソリフェナシン錠剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のイトプリド塩酸塩錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のオキシコドン塩酸徐放性錠剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアトルバスタチンカルシウム錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のボリコナゾール錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のクロナゼパム錠市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆